ncRNA name
hsa-miR-101-3p
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
Not available
Cancer name
Multiple Myeloma
Cancer site
Multiple Myeloma
Treatment type
Chemotherapy
Drug
Bortezomib
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
BMSC-induced resistance to drugs is associated with survivin upregulation which is a direct target of miR-101-3p.
Tissue resource
immortalized human bone marrow stromal cell lines HS-5
human myeloma cell lines HMCLs
human myeloma cell lines RPMI-8226
human myeloma cell lines U266
human myeloma cell lines MM.1S
human myeloma cell lines OPM2
Experiment
RT-PCR
Institute
American Type Culture Collection
Country
USA
Continent
North American